Highlights from ThoughtSpot 2022

August 08, 2022 03:22pm

A quick video recap of all the sessions and events ThoughtSpot 2022 had to offer.

Vivjoa Approved for Recurrent Vulvovaginal Candidiasis
Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea
HER2 Low Breast Cancer Therapy Enhertu Approved by FDA
Pharmacists Fight to Take on Opioid Use Disorder